What should I know first?
Amphetamines affect dopamine and norepinephrine signaling through both reuptake and release. This view uses Adderall XR, an extended-release mixed amphetamine-salt product.
The U.S. Adderall XR label covers ADHD in adults and children aged 6 and older. It has serious misuse and addiction risks. This is not a dose-conversion or product-substitution guide.
This is a mechanism lesson, not a complete medicine guide. A diagram cannot choose treatment, predict your response, or tell you how to change a prescription.
Adderall XR is not recommended for children under 6 because they can have higher drug exposure and more adverse effects, including weight loss. This restriction concerns the named extended-release product; it does not establish the approval or safety of another formulation. For age-specific treatment and monitoring information, see the ADHD medication article.
How Brain Cells Communicate
A nerve ending stores messengers in small packets called vesicles. Releasing a messenger into the space outside a cell and returning it through a transporter are different processes.
Dopamine · DAT
- Dopamine
The messenger is shown outside the sending cell.
- DAT
The DAT transporter returns dopamine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Norepinephrine · NET
- Norepinephrine
The messenger is shown outside the sending cell.
- NET
The NET transporter returns norepinephrine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
About this illustration
Messenger return runs from outside toward the nerve cell. This is distinct from release from inside to outside.
How the Medication Changes Signaling
Amphetamine pharmacology includes inhibition of dopamine and norepinephrine reuptake and increased release of these messengers outside nerve cells. The outward arrow in the release panel represents the latter effect; it is not the same inward reuptake arrow.
Experiments comparing amphetamine isomers with methylphenidate found different effects on storage and release. The exact effects vary with the preparation and measurement. No universal release rate is shown.
Explore the mechanism
Which direction does release take?
Dopamine · DAT
- Dopamine
The messenger is shown outside the sending cell.
- DAT
The DAT transporter returns dopamine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Norepinephrine · NET
- Norepinephrine
The messenger is shown outside the sending cell.
- NET
The NET transporter returns norepinephrine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Dopamine · DAT
- Dopamine
The messenger is shown outside the sending cell.
- DAT
The DAT transporter returns dopamine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Norepinephrine · NET
- Norepinephrine
The messenger is shown outside the sending cell.
- NET
The NET transporter returns norepinephrine into the cell.
- Return into the cell
The arrow shows transport direction, without a measured rate.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Dopamine · DAT
- Dopamine
The messenger is shown outside the sending cell.
- DAT
The DAT transporter returns dopamine into the cell.
- Amphetamine: uptake inhibited
The interrupted arrow names the action; the symbol is not a molecular shape or binding position.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Norepinephrine · NET
- Norepinephrine
The messenger is shown outside the sending cell.
- NET
The NET transporter returns norepinephrine into the cell.
- Amphetamine: uptake inhibited
The interrupted arrow names the action; the symbol is not a molecular shape or binding position.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Dopamine · DAT
- Dopamine
The messenger is shown outside the sending cell.
- DAT
The DAT transporter returns dopamine into the cell.
- Increased release
The outward arrow shows a net effect, not an exclusive molecular route.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
Norepinephrine · NET
- Norepinephrine
The messenger is shown outside the sending cell.
- NET
The NET transporter returns norepinephrine into the cell.
- Increased release
The outward arrow shows a net effect, not an exclusive molecular route.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
What this model cannot tell us
Clinical mechanism unknown
- Clinical mechanism unknown The clinical explanation remains uncertain.
- Limits of inference An experimental result does not by itself predict one person’s treatment response.
Static overview. Start the steps when you are ready.
Reduced motion is on. Use the step buttons or read the complete sequence.
Guide to the illustration: Outlines identify a cell membrane or target; arrows mark the direction explained in each caption. Medicine symbols are labels, not measured shapes or binding poses. No quantity, size or rate is to scale.
Read the complete sequence
- Before medicine: reuptake. Messenger return runs from outside toward the nerve cell. This is distinct from release from inside to outside.
- Reuptake inhibition. Amphetamines inhibit dopamine and norepinephrine reuptake. This panel does not yet represent their additional release effect.
- Increased release. The outward arrow marks increased messenger release into the space outside the nerve cell. This is a qualitative net effect, not a verified animation of every molecular step.
- Separate clinical question. The target actions do not fully explain therapeutic effects in ADHD or determine the right medicine for an individual.
Evidence and model limits
Adderall XR label12.1/12.2; experimental uptake and release in rat nerve-ending/vesicle preparations.
The release arrow shows movement to the outside, not a complete transporter cycle or an atomic mechanism. Rates and relative effects are not inferred.
A Closer Look at the Molecular Level
Known actions: increased release and reuptake inhibition are described in the current Adderall XR label. This formulation contains mixed amphetamine salts, not one newly invented molecule.
Clinical uncertainty: its therapeutic mode of action in ADHD remains unknown. A simplified cell drawing cannot rank stimulant medicines, predict an individual’s response or equate extended-release products.
Sources and References
The sources below support the specific medicine and experimental context described here. Drawings are original qualitative teaching models; positions, arrows and timing do not give atomic geometry, occupancy or rates.
Article Information
- Content updated
- 2026-10-30
- Sources checked
- 2026-10-16
- Publication status
- Published
Illustration information
- Which direction does release take?
Checked 2026-10-16 · Created for Psychiatry Atlas · Original project artwork

